McKesson logo

McKesson

MCKNYSEStock Fundamentals

McKesson Corporation is a leading global healthcare services company that provides pharmaceutical distribution, medical-surgical supply logistics, and healthcare technology solutions. The company serves as a critical link in the healthcare supply chain, connecting biopharmaceutical manufacturers and medical suppliers with pharmacies, hospitals, and physician practices to improve patient outcomes and operational efficiency.

Market Cap$93.3B
Revenue TTM$403.43B
Net Income TTM$4.8B
P/E Ratio19.59
Net Margin1.18%
EPS TTM$38.38
Free Cash Flow TTM$5.7B
Employees51.0K
CEOBrian S. Tyler
CountryUnited States of America
Healthcare
Medical - Distribution
SegmentsHealthcare Distribution, Healthcare Technology, Pharmaceutical Wholesaling
Business ModelsWholesale distribution, B2B services, Franchising, Software-as-a-Service (SaaS)
Most Recent EarningsMay 7, 2026 · 13 days agoQ1 2026 · FQ4 FY2026
View report
Next EarningsAug 5, 2026 · in 2 monthsAfter Market Close · Q2 2026 · FQ1 FY2027

Financials

Based on Q1 2026 · FQ4 FY2026 filing

Gross Margin3.61%
Op. Margin1.54%
ROE-224.31%
D/E-104.83%
Current Ratio0.854
Total Debt$2.3B
Cash$4.0B
CapEx TTM$436.0M

Gross Profit

View metric

Net Income

View metric

Operating Cash Flow

View metric

Free Cash Flow

View metric

EPS (Diluted)

View metric

Business Segments

U.S. Pharmaceutical

primary

Distributes branded, generic, specialty, and over-the-counter pharmaceutical drugs and healthcare-related products across the United States. It also provides practice management, clinical support, and business solutions to specialty practices, including oncology.

Products

McKesson Connect, Health Mart, Health Mart Atlas, McKesson SynerGx, Central Fill, McKesson OneStop Generics, McKesson Reimbursement Advantage

Customers

Retail national accounts, Community pharmacies, Hospitals, Oncology practices, Health systems

Medical-Surgical Solutions

major

Provides medical-surgical supply distribution, logistics, and biomedical maintenance services to healthcare providers across the alternate-site spectrum. The company announced an intention to separate this segment into an independent company in 2025.

Products

McKesson Brand medical supplies, Gloves, Needles, Syringes, Infusion pumps, Laboratory equipment

Customers

Physician offices, Surgery centers, Nursing homes, Home health care agencies

Prescription Technology Solutions (RxTS)

moderate

Connects patients, pharmacies, providers, and biopharma companies to address medication access, affordability, and adherence challenges. The segment provides technology-driven services such as electronic prior authorization and prescription price transparency.

Products

Electronic prior authorization, Prescription price transparency, Benefit insight, Dispensing support services

Customers

Biopharma companies, Pharmacy benefit managers, Health plans, Providers

International

moderate

Operates pharmaceutical wholesale and retail distribution businesses in Canada and Norway. This segment provides automation, technology solutions, and specialty health services to retail and hospital customers in these markets.

Products

IDA, Guardian, The Medicine Shoppe, Remedy’sRx, INVIVA infusion clinics, PDCI consultancy

Customers

Retail pharmacies, Institutional customers, Wholesale customers, Canadian provincial governments

Segment Financials

North American Pharmaceutical — Revenue derived from services (less than) (as a percent)

View metric

North American Pharmaceutical — Non-cash charges

View metric

Oncology & Multispecialty — Integration-related cost, expense

View metric

Medical-Surgical Solutions — Other

View metric

Medical-Surgical Solutions — Revenue derived from services (less than) (as a percent)

View metric

Medical-Surgical Solutions — Separation costs

View metric

Prescription Technology Solutions — Revenue derived from services (less than) (as a percent)

View metric

Prescription Technology Solutions — Non-cash charges

View metric

Prescription Technology Solutions — Other

View metric

North American Pharmaceutical — Other

View metric

Business Overview

Competitive Position

McKesson is one of the largest pharmaceutical distributors in North America, leveraging massive scale and a diversified portfolio of technology and clinical services to maintain a leading market position.

Geographies

United States, Canada, Norway

Customer Segments

Pharmacies, Hospitals, Biopharmaceutical manufacturers, Physician practices

Upstream Dependencies

Pharmaceutical manufacturers, Medical-surgical equipment manufacturers, Generic drug producers, Biotechnology firms

Downstream Customers

Retail pharmacy chains, Independent pharmacies, Hospitals and health systems, Specialty clinics, Government healthcare agencies

McKesson logo

McKesson FAQ

Common questions about McKesson

McKesson Corporation is a leading global healthcare services company that provides pharmaceutical distribution, medical-surgical supply logistics, and healthcare technology solutions. The company serves as a critical link in the healthcare supply chain, connecting biopharmaceutical manufacturers and medical suppliers with pharmacies, hospitals, and physician practices to improve patient outcomes and operational efficiency.

McKesson (MCK) has a market capitalization of $93.3B and trades on NYSE.

McKesson generated $403.43B in trailing twelve-month revenue with net income of $4.8B, representing a net margin of 1.2%. Gross margin stands at 3.6%, with free cash flow of $5.7B. These figures are based on the Q1 2026 filing.

McKesson's key competitors include Cencora, Inc., Cardinal Health, Inc., Medline Inc. Class A common stock, and others. These companies compete in similar markets and product categories.

McKesson has approximately 51,000 employees.